Donald Bellgrau

Founder at ApopLogic Pharmaceuticals, Inc.

Consumer Services

Health Technology

Profile

Donald Bellgrau is the founder of GlobeImmune, Inc. (founded in 1995) and ApopLogic Pharmaceuticals, Inc. (founded in 2006).
At ApopLogic Pharmaceuticals, Inc., he holds the title of Director & Founding Scientist.
Currently, Dr. Bellgrau is a Professor at The University of Colorado.
In the past, he worked as a Member-Scientific Staff at the Basel Institute for Immunology.
He obtained his doctorate degree from the University of Pennsylvania.

Donald Bellgrau active positions

Companies	Position	Start
The University of Colorado	Corporate Officer/Principal	13/09/2009
ApopLogic Pharmaceuticals, Inc. ApopLogic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ApopLogic Pharmaceuticals, Inc. researches and develops pharmaceutical products. It focuses on the development and commercialization of B201, is a rationally-designed synthetic peptide dimer of a potent decapeptide bradykinin B1&B2 receptor antagonist that directly induces apoptosis of cancer cells that overexpress these receptors and AP-300 is used in the neo-adjuvant or adjuvant setting with standard-of-care agents to improve survival outcomes in humans and companion animals with any accessible solid tumor including carcinomas, sarcomas and lymphomas. The company was founded in 2006 by Richard C. Duke, Donald Bellgrau, Paul A. Bunn, Daniel Chan, Lajos Gera, Jaime F. Modiano and John M. Stewart and is headquartered in Aurora, CO.	Founder	31/12/2005

All active positions of Donald Bellgrau

Former positions of Donald Bellgrau

Companies	Position	End
GLOBEIMMUNE, INC.	Founder	-
Basel Institute for Immunology	Corporate Officer/Principal	-

See the detail of Donald Bellgrau's experience

Training of Donald Bellgrau

University of Pennsylvania

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Donald Bellgrau's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
GLOBEIMMUNE, INC.	Health Technology

Private companies	1
ApopLogic Pharmaceuticals, Inc. ApopLogic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ApopLogic Pharmaceuticals, Inc. researches and develops pharmaceutical products. It focuses on the development and commercialization of B201, is a rationally-designed synthetic peptide dimer of a potent decapeptide bradykinin B1&B2 receptor antagonist that directly induces apoptosis of cancer cells that overexpress these receptors and AP-300 is used in the neo-adjuvant or adjuvant setting with standard-of-care agents to improve survival outcomes in humans and companion animals with any accessible solid tumor including carcinomas, sarcomas and lymphomas. The company was founded in 2006 by Richard C. Duke, Donald Bellgrau, Paul A. Bunn, Daniel Chan, Lajos Gera, Jaime F. Modiano and John M. Stewart and is headquartered in Aurora, CO.	Health Technology